Biocept Q3 EPS $(0.25) Beats $(0.27) Estimate, Sales $1.53M Beat $1.45M Estimate

Biocept (NASDAQ:BIOC) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.27) by 7.41 percent. This is a 89.67 percent increase over losses of $(2.42) per share from the same

Benzinga · 11/13/2019 21:08

Biocept (NASDAQ:BIOC) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.27) by 7.41 percent. This is a 89.67 percent increase over losses of $(2.42) per share from the same period last year. The company reported quarterly sales of $1.53 million which beat the analyst consensus estimate of $1.45 million by 5.52 percent. This is a 100.90 percent increase over sales of $761.591 thousand the same period last year.